Lordosis
Welcome,         Profile    Billing    Logout  
 1 Company   1 Product   1 Product   0 Mechanisms of Action   0 Trials   24 News 
  • ||||||||||  Zorbtive (somatropin) / EMD Serono
    Trial completion, Enrollment change, Trial initiation date, Trial primary completion date:  Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen (clinicaltrials.gov) -  Jun 20, 2017   
    P2,  N=19, Completed, 
    Active, not recruiting --> Completed | N=10 --> 19 | Initiation date: Jun 2009 --> Mar 2006 | Trial primary completion date: Apr 2018 --> Jan 2017
  • ||||||||||  Enrollment change, Surgery:  Comparison of Actifuse ABX and Local Bone in Spinal Surgery (clinicaltrials.gov) -  Apr 28, 2017   
    P4,  N=14, Terminated, 
    Active, not recruiting --> Completed | N=10 --> 19 | Initiation date: Jun 2009 --> Mar 2006 | Trial primary completion date: Apr 2018 --> Jan 2017 N=60 --> 14
  • ||||||||||  Trial completion, Trial primary completion date:  Adolescent Idiopathic Scoliosis (AIS) Patient Positioning in EOS System (clinicaltrials.gov) -  Dec 16, 2016   
    P=N/A,  N=37, Completed, 
    N=60 --> 14 Enrolling by invitation --> Completed | Trial primary completion date: Nov 2016 --> Aug 2015
  • ||||||||||  Trial termination:  Correlation Between Sagittal Balance of the Spine and Psychopathological Profile (clinicaltrials.gov) -  Apr 7, 2016   
    P=N/A,  N=205, Terminated, 
    Enrolling by invitation --> Completed | Trial primary completion date: Nov 2016 --> Aug 2015 Recruiting --> Terminated; Departure of psychologist in charge of questionnaires and scales administered to patients as part of the evaluation of primary endpoint
  • ||||||||||  Zorbtive (somatropin) / EMD Serono
    Enrollment change, Trial initiation date:  Efficacy and Safety Evaluation of Recombinant Human Growth Hormone (r-hGH), Saizen (clinicaltrials.gov) -  Jul 21, 2015   
    P2,  N=9, Active, not recruiting, 
    Recruiting --> Terminated; Departure of psychologist in charge of questionnaires and scales administered to patients as part of the evaluation of primary endpoint N=19 --> 9 | Initiation date: Mar 2006 --> Jun 2009
  • ||||||||||  Trial completion:  C-Type Natriuretic Peptide and Achondroplasia (clinicaltrials.gov) -  Apr 14, 2015   
    P=N/A,  N=91, Completed, 
    Recruiting --> Completed Active, not recruiting --> Completed
  • ||||||||||  Enrollment closed:  C-Type Natriuretic Peptide and Achondroplasia (clinicaltrials.gov) -  Oct 2, 2014   
    P=N/A,  N=100, Active, not recruiting, 
    Not yet recruiting --> Enrolling by invitation Enrolling by invitation --> Active, not recruiting